Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells
- 1 March 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (3) , 659-666
- https://doi.org/10.1161/01.atv.20.3.659
Abstract
Abstract —Vascular endothelial growth factor (VEGF) is known to induce the release of nitric oxide (NO) from endothelial cells. However, the effect of NO on VEGF synthesis is not clear. Accordingly, the effect of endogenous and exogenous NO on VEGF synthesis by rat vascular smooth muscle cells (VSMCs) was investigated. Two in vitro models were used: (1) VSMCs stimulated to produce NO by treatment with interleukin (IL)-1β (10 ng/mL) and (2) VSMCs lipotransfected with pKecNOS plasmid, containing the endothelial constitutive NO synthase (ecNOS) cDNA. The synthesis of NO was inhibited by N ω -nitro- l -arginine methyl ester (L-NAME, 2 to 5 mmol/L) or diaminohydroxypyrimidine (DAHP, 2.5 to 5 mmol/L), inhibitors of NOS and GTP cyclohydrolase I, respectively. Some cells treated with L-NAME or DAHP were supplemented with l -arginine (10 mmol/L) or tetrahydrobiopterin (BH 4 ; 100 μmol/L), respectively. In addition, we studied the effect of sodium nitroprusside (SNP; 10 and 100 μmol/L) and chemically related compounds, potassium ferrocyanide and ferricyanide, on VEGF generation. IL-1β induced iNOS expression and NO generation and significantly upregulated VEGF mRNA expression and protein synthesis. L-NAME and DAHP totally inhibited NO generation and decreased the IL-1β–upregulated VEGF synthesis by 30% to 40%. Supplementation with l -arginine or BH 4 increased NO generation by L-NAME– or DAHP-treated cells, and VEGF synthesis was augmented by addition of BH 4 . The cells generating NO after pKecNOS transfection released significantly higher amounts of VEGF than cells transfected with control plasmids. Inhibition of NO generation by L-NAME decreased VEGF synthesis. In contrast to the effect of endogenous NO, we observed the inhibition of VEGF synthesis in the presence of high (10 or 100 μmol/L) concentrations of SNP. This effect was mimicked by chemically related ferricyanide and ferrocyanide compounds, suggesting that the inhibitory effect of sodium nitroprusside may be mediated by an NO-independent mechanism. The results indicate that endogenous NO enhances VEGF synthesis. The positive interaction between endogenous NO and VEGF may have implications for endothelial regeneration after balloon angioplasty and for angiogenesis.Keywords
This publication has 30 references indexed in Scilit:
- Production of Vascular Endothelial Growth Factor by Murine MacrophagesThe American Journal of Pathology, 1998
- Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cellsOncogene, 1997
- Dissociation of lipopolysaccharide-mediated induction of nitric oxide synthase and inhibition of DNA synthesis in RAW 264.7 macrophages and rat aortic smooth muscle cellsBritish Journal of Pharmacology, 1997
- Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial CellsJournal of Biological Chemistry, 1995
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cellsFEBS Letters, 1995
- Nitric Oxide Promotes DNA Synthesis and Cyclic GMP Formation in Endothelial Cells from Postcapillary VenulesBiochemical and Biophysical Research Communications, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Induction of nitric oxide synthase by cytokines in vascular smooth muscle cellsFEBS Letters, 1990